vs

Side-by-side financial comparison of NORTHPOINTE BANCSHARES INC (NPB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.4M, roughly 1.3× NORTHPOINTE BANCSHARES INC). NORTHPOINTE BANCSHARES INC runs the higher net margin — 34.9% vs -38.1%, a 73.0% gap on every dollar of revenue.

Northpointe Bancshares Inc is a U.S.-based bank holding company operating through its wholly-owned banking subsidiary. It provides a full suite of retail and commercial banking solutions, including deposit accounts, mortgage loans, small business lending, and wealth management services, primarily serving local and regional community markets across the United States.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NPB vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$63.4M
NPB
Higher net margin
NPB
NPB
73.0% more per $
NPB
34.9%
-38.1%
PRCT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NPB
NPB
PRCT
PRCT
Revenue
$63.4M
$83.1M
Net Profit
$22.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
34.9%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.62
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPB
NPB
PRCT
PRCT
Q1 26
$63.4M
$83.1M
Q4 25
$43.5M
$76.4M
Q3 25
$40.3M
$83.3M
Q2 25
$36.5M
$79.2M
Q1 25
$30.4M
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
NPB
NPB
PRCT
PRCT
Q1 26
$22.2M
$-31.6M
Q4 25
$23.6M
$-29.8M
Q3 25
$22.2M
$-21.4M
Q2 25
$20.3M
$-19.6M
Q1 25
$17.2M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
NPB
NPB
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
NPB
NPB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
73.5%
-40.6%
Q3 25
72.3%
-27.8%
Q2 25
73.0%
-28.0%
Q1 25
74.4%
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
NPB
NPB
PRCT
PRCT
Q1 26
34.9%
-38.1%
Q4 25
54.4%
-39.1%
Q3 25
55.0%
-25.7%
Q2 25
55.7%
-24.7%
Q1 25
56.8%
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
NPB
NPB
PRCT
PRCT
Q1 26
$0.62
$-0.56
Q4 25
$0.54
$-0.54
Q3 25
$0.57
$-0.38
Q2 25
$0.51
$-0.35
Q1 25
$0.49
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPB
NPB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$487.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$590.0M
$347.7M
Total Assets
$7.4B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPB
NPB
PRCT
PRCT
Q1 26
$487.6M
$245.6M
Q4 25
$496.5M
$286.5M
Q3 25
$419.2M
$294.3M
Q2 25
$415.7M
$302.7M
Q1 25
$321.5M
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
NPB
NPB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
NPB
NPB
PRCT
PRCT
Q1 26
$590.0M
$347.7M
Q4 25
$569.0M
$365.9M
Q3 25
$623.5M
$380.3M
Q2 25
$604.3M
$385.8M
Q1 25
$586.5M
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
NPB
NPB
PRCT
PRCT
Q1 26
$7.4B
$487.1M
Q4 25
$7.0B
$508.1M
Q3 25
$6.8B
$511.5M
Q2 25
$6.4B
$513.1M
Q1 25
$5.9B
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
NPB
NPB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPB
NPB

Net Interest Income$41.3M65%
Noninterest Income$22.1M35%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons